Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?

被引:28
作者
Eriksson, U [1 ]
Opravil, M [1 ]
Amann, FW [1 ]
Schaffner, A [1 ]
机构
[1] Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland
关键词
D O I
10.1097/00002030-199815000-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2079 / 2080
页数:2
相关论文
共 13 条
[11]   A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection [J].
Rutschmann, OT ;
Opravil, M ;
Iten, A ;
Malinverni, R ;
Vernazza, PL ;
Bucher, HC ;
Bernasconi, E ;
Sudre, P ;
Leduc, D ;
Yerly, S ;
Perrin, LH ;
Hirschel, B .
AIDS, 1998, 12 (08) :F71-F77
[12]  
Sullivan AK, 1997, AIDS, V11, P938
[13]  
ZANGERLE R, 1994, J ACQ IMMUN DEF SYND, V7, P1149